SCHEMBL97156

SCHEMBL97156

O=Cc1ccc2occcc1-2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 4/20 0.46
ALDH1A1 P00352 5/20 0.45
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
BLM P54132 3/20 0.37
TDP1 Q9NUW8 3/20 0.37
THRB P10828 3/20 0.37
LMNA P02545 2/20 0.37
POLB P06746 5/20 0.35
MAPT P10636 4/20 0.35
L3MBTL1 Q9Y468 4/20 0.35
KDM4E B2RXH2 2/20 0.35
PKM P14618 2/20 0.35
HPGD P15428 2/20 0.35
ALOX15 P16050 2/20 0.35
CASP1 P29466 2/20 0.35
PTPN7 P35236 2/20 0.35
RECQL P46063 2/20 0.35
CASP7 P55210 2/20 0.35
HSD17B10 Q99714 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL610633 0.90 ERN1 (0.49) ERN1ALDH1A1MEN1KMT2ABLM
SCHEMBL448220 0.79 ALDH1A1 (0.35) ERN1ALDH1A1MEN1KMT2ABLM
SCHEMBL452371 0.79 POLB (0.35) ERN1ALDH1A1MEN1KMT2ABLM
SCHEMBL27629482 0.79 HTR1A (0.36) ALDH1A1MEN1KMT2ABLMTDP1
SCHEMBL13388773 0.78 ERN1 (0.50) ERN1ALDH1A1MEN1KMT2AMAPT
SCHEMBL27287781 0.76 ERN1 (0.47) ERN1ALDH1A1MEN1KMT2ABLM
SCHEMBL3665852 0.75 KMT2A (0.64) ERN1ALDH1A1MEN1KMT2ALMNA
SCHEMBL7394090 0.75 ERN1 (0.43) ERN1ALDH1A1MEN1KMT2ABLM
SCHEMBL28403249 0.73 LMNA (0.41) ERN1ALDH1A1MEN1KMT2ABLM
SCHEMBL28514390 0.72 CDK4 (0.46) ERN1ALDH1A1MEN1KMT2ABLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102190661-B Tricyclic benzopyran compound as anti-arrhythmic agents NISSAN CHEMICAL IND LTD 2013-07-31 CN disclosed
US-8394974-B2 Process for producing optically active chromene oxide compound NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2013-03-12 US disclosed
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 US disclosed
CN-1934116-B Tricyclic benzopyran compounds useful as antiarrhythmic agents NISSAN CHEMICAL IND LTD 2012-10-10 CN disclosed
EP-1797082-B1 CARBOSTYRIL COMPOUND OTSUKA PHARMA CO LTD (JP) 2012-08-29 EP disclosed
CN-101437827-B Process for producing optically active chromene oxide compound NISSAN CHEMICAL IND LTD 2012-08-29 CN disclosed
CN-102603683-A Furan compound and preparation method and application of furan compound UNIV SHANDONG 2012-07-25 CN disclosed
CN-101429200-B Tricyclic benzopyran compound as anti-arrhythmic agents NISSAN CHEMICAL IND LTD 2012-05-30 CN disclosed
EP-2426128-A1 Carbostyril compound Otsuka Pharmaceutical Co., Limited (JP) 2012-03-07 EP disclosed
CN-102190661-A Tricyclic benzopyran compound as anti-arrhythmic agents NISSAN CHEMICAL IND LTD 2011-09-21 CN disclosed
EP-2003135-A2 PROCESS FOR PRODUCING OPTICALLY ACTIVE CHROMENE OXIDE COMPOUND Nissan Chemical Industries, Ltd. (JP) 2008-12-17 EP disclosed
WO-2008010601-A1 NF- ϰB INHIBITOR OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2008-01-24 WO disclosed
US-20080004262-A1 Tricyclic Benzopyrane Compound as Anti-Arrhythmic Agents NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2008-01-03 US disclosed
CN-101068810-A Carbostyril compound OTSUKA PHARMA CO LTD (JP) 2007-11-07 CN disclosed
US-20070179173-A1 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-02 US disclosed
EP-1797082-A1 CARBOSTYRIL COMPOUND Otsuka Pharmaceutical Company, Limited (JP) 2007-06-20 EP disclosed
CN-1934116-A Tricyclic benzopyran compounds useful as antiarrhythmic agents NISSAN CHEMICAL IND LTD (JP) 2007-03-21 CN disclosed
EP-1732929-A1 TRICYCLIC BENZOPYRAN COMPOUND AS ANTI-ARRHYTHMIC AGENTS Nissan Chemical Industries, Ltd. (JP) 2006-12-20 EP disclosed
WO-2006035954-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-04-06 WO disclosed
WO-2005090357-A1 TRICYCLIC BENZOPYRAN COMPOUND AS ANTI-ARRHYTHMIC AGENTS NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2005-09-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070179173-A1 Carbostyril compound GTF2F1, F3, GTF2F2 ERN1 3550/4885ALDH1A1 2458/4885MEN1 3912/4885
US-20080004262-A1 Tricyclic Benzopyrane Compound as Anti-Arrhythmic Agents CBR1, CBR3, SCN8A ERN1 2050/4885ALDH1A1 2087/4885MEN1 4065/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.